US Patent 7129272 Apoptosis inhibitor
All edits
Edits on 31 Aug, 2023
Golden AI
Edits made to:
Article (+263 characters)
Article
Patent abstract
Disclosed is a method for treatment of a subject having a disease or condition associated with apoptosis, which comprises administering to the subject an effective amount of a 15-keto-prostaglandin compound represented by the following formula (I):
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07129272 Apoptosis inhibitor US Patent 7129272 Apoptosis inhibitor
Infobox
Patent Number
0712927200
Patent Number
712927200
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 7 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
071292720
Date of Patent
October 31, 2006
0Patent Application Number
098166550
Date Filed
March 26, 2001
0Official Website
Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
071292720
Date of Patent
October 31, 2006
0Patent Application Number
098166550
Date Filed
March 26, 2001
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 18 Nov, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07129272 Apoptosis inhibitor
Infobox
Is a
Patent jurisdiction
Patent number
07129272
Date of patent
October 31, 2006
Patent application number
09816655
Date Filed
March 26, 2001
Patent primary examiner
Find more entities like US Patent 7129272 Apoptosis inhibitor
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.